Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04766996 · ClinicalTrials.gov registry record · Phase 4
PROUD Study - Preventing Opioid Use Disorders
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
NCT04766996 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 57 participants.
The verdict
NCT04766996, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
Study Summary
The objective of this study is to pilot an opioid free anesthetic protocol for patients undergoing total hip replacement.
Interventions
- DRUG Pregabalin
- BEHAVIORAL Guided mindfulness exercises
- OTHER Self-administered aromatherapy
- DRUG Baby aspirin
- DRUG Tylenol/Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2021-12-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04766996
The ClinicalTrials.gov registry entry for NCT04766996 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Pregabalin is the first listed.
NCT04766996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04766996 about?
NCT04766996 is a clinical study titled "PROUD Study - Preventing Opioid Use Disorders". The objective of this study is to pilot an opioid free anesthetic protocol for patients undergoing total hip replacement.
What is the current status of trial NCT04766996?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2021-05-17. Estimated completion is 2021-12-27.
What interventions are being tested in trial NCT04766996?
The interventions under investigation include: Pregabalin (DRUG), Guided mindfulness exercises (BEHAVIORAL), Self-administered aromatherapy (OTHER), Baby aspirin (DRUG), Tylenol/Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT04766996?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.